Cognition Therapeutics (CGTX) Research & Development (2020 - 2026)
Cognition Therapeutics (CGTX) reported Research & Development of $5.1 million for Q2 2026, down 55.6% from $11.48 million a year earlier and down 16.7% from the prior quarter.
Powered by 
Analysis
Cognition Therapeutics (CGTX) Research & Development (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cognition Therapeutics' Research & Development came in at $26.14 million, down 37.5% year-over-year; for FY2025, it came in at $37.19 million, down 10.8% from FY2024.
- Research & Development has a five-year compound annual growth rate of 23.6% (FY2020 to FY2025).
- By year, Research & Development came in at $41.68 million in FY2024 (+12.0%), $37.2 million in FY2023 (+22.7%), $30.32 million in FY2022 (+63.3%) and $18.57 million in FY2021 (+44.1%).
- Five-year quarterly Research & Development spans a low of $3.68 million in Q3 2021 and a high of $11.67 million in Q3 2023.
- Year over year, Research & Development gained in two of the last eight quarters, with an average decline of 20.0%.
- The high point for year-over-year Research & Development in five years was Q3 2022 (growth of 125.0%); the low point was Q3 2025 (a decline of 66.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.12 million (Q1 2026), $11.15 million (Q4 2025) and $3.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Cognition Therapeutics | 91.25 Mn | 91.25 Mn | - | 5.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.10 Mn |
| Mar 31, 2026 | 6.12 Mn |
| Dec 31, 2025 | 11.15 Mn |
| Sep 30, 2025 | 3.77 Mn |
| Jun 30, 2025 | 11.48 Mn |
| Mar 31, 2025 | 10.79 Mn |
| Dec 31, 2024 | 8.15 Mn |
| Sep 30, 2024 | 11.39 Mn |
| Jun 30, 2024 | 11.58 Mn |
| Mar 31, 2024 | 10.55 Mn |
| Dec 31, 2023 | 11.60 Mn |
| Sep 30, 2023 | 11.67 Mn |
| Jun 30, 2023 | 8.50 Mn |
| Mar 31, 2023 | 5.43 Mn |
| Dec 31, 2022 | 9.10 Mn |
| Sep 30, 2022 | 8.27 Mn |
| Mar 31, 2022 | 6.52 Mn |
| Dec 31, 2021 | 5.57 Mn |
| Sep 30, 2021 | 3.68 Mn |
| Dec 31, 2020 | 3.29 Mn |
API Access
Cognition Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();